Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,365,368
-
Total 13F shares
-
9,151,395
-
Share change
-
-480,705
-
Total reported value
-
$44,281,000
-
Price per share
-
$4.84
-
Number of holders
-
26
-
Value change
-
-$2,331,016
-
Number of buys
-
10
-
Number of sells
-
16
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q2 2016
As of 30 Jun 2016,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,151,395 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, Redmile Group, LLC, Clearbridge Investments, LLC, JANUS CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, FMR LLC, ALTRINSIC GLOBAL ADVISORS LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.